{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:28:56Z","timestamp":1789993736823,"version":"4.0.1"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2017,4,20]],"date-time":"2017-04-20T00:00:00Z","timestamp":1492646400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100000836","name":"University of Liverpool MRes Clinical Sciences Research Support Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000836","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of Liverpool Faculty of Health and Life Sciences"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,7,13]]},"abstract":"<jats:title>Summary<\/jats:title>\n               <jats:p>Neutrophils play a crucial role in the pathophysiology of rheumatoid arthritis (RA) via the release of reactive oxygen species (ROS), proteases and cytokines. Orally active Janus kinase (JAK) inhibitors (JAKi), e.g. baricitinib and tofacitinib, have high clinical efficacy in RA but are linked with neutropenia and increased infections. Our aim was to determine the effect of JAK inhibition with baricitinib and tofacitinib on healthy control and RA neutrophil lifespan and function. RA (n = 7) and healthy control (n = 7) neutrophils were treated with baricitinib or tofacitinib for 30 min, prior to incubation in the absence or presence of granulocyte\u2013macrophage colony-stimulating factor (GM-CSF) or interferon (IFN)-\u03b3. JAKi prevented GM-CSF- and IFN-\u03b3-induced apoptosis delay in RA and healthy control neutrophils in a dose-dependent manner. Baricitinib decreased the rate of chemotaxis towards interleukin (IL)-8, but not f-Met-Leu-Phe (fMLP) in RA neutrophils. While healthy control neutrophils incubated with GM-CSF became primed to produce ROS in response to stimulation with fMLP and phorbol-12-myristate-12-acetate (PMA), RA neutrophils produced increased levels of ROS without the need for priming. JAKi prevented ROS release from primed healthy control neutrophils in response to fMLP, but had no effect on ROS production by RA neutrophils. Baricitinib reversed GM-CSF priming of ROS production in response to fMLP in healthy control, but not RA, neutrophils. We conclude that incubation with JAKi prevents chemotaxis of RA neutrophils towards IL-8, but does not prevent the production of ROS or increase the level of apoptosis. This may be due to the in-vivo exposure of RA neutrophils to priming agents other than those that activate JAK\/signal transducer and activator of transcription (STAT) signalling.<\/jats:p>","DOI":"10.1111\/cei.12970","type":"journal-article","created":{"date-parts":[[2017,4,4]],"date-time":"2017-04-04T22:31:54Z","timestamp":1491345114000},"page":"250-258","source":"Crossref","is-referenced-by-count":58,"title":["Janus kinase inhibitors prevent migration of rheumatoid arthritis neutrophils towards interleukin-8, but do not inhibit priming of the respiratory burst or reactive oxygen species production"],"prefix":"10.1093","volume":"189","author":[{"given":"T S","family":"Mitchell","sequence":"first","affiliation":[{"name":"Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R J","family":"Moots","sequence":"additional","affiliation":[{"name":"Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0442-3134","authenticated-orcid":false,"given":"H L","family":"Wright","sequence":"additional","affiliation":[{"name":"Institute of Integrative Biology, University of Liverpool, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,4,20]]},"reference":[{"key":"2021120808115213100_cei12970-bib-0001","first-page":"318","article-title":"The mechanism of action of tofacitinib \u2013 an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis","volume":"34","author":"Hodge","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"2021120808115213100_cei12970-bib-0002","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0140-6736(12)61424-X","article-title":"Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial","volume":"381","author":"Burmester","year":"2013","journal-title":"Lancet"},{"key":"2021120808115213100_cei12970-bib-0003","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1056\/NEJMoa1109071","article-title":"Placebo-controlled trial of tofacitinib monotherapy in rheumatoid arthritis","volume":"367","author":"Fleischmann","year":"2012","journal-title":"N Engl J Med"},{"key":"2021120808115213100_cei12970-bib-0004","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/annrheumdis-2016-210094","article-title":"Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study","volume":"76","author":"Dougados","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2021120808115213100_cei12970-bib-0005","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1056\/NEJMoa1112072","article-title":"Tofacitinib or adalimumab versus placebo in rheumatoid arthritis","volume":"367","author":"van Vollenhoven","year":"2012","journal-title":"N Engl J Med"},{"key":"2021120808115213100_cei12970-bib-0006","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1002\/art.34329","article-title":"The JAK inhibitor tofacitinib regulates synovitis through inhibition of interferon-gamma and interleukin-17 production by human CD4+ T cells","volume":"64","author":"Maeshima","year":"2012","journal-title":"Arthritis Rheum"},{"key":"2021120808115213100_cei12970-bib-0007","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1136\/annrheumdis-2014-206028","article-title":"The JAK inhibitor tofacitinib suppresses synovial JAK1-STAT signalling in rheumatoid arthritis","volume":"74","author":"Boyle","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2021120808115213100_cei12970-bib-0008","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/nrrheum.2014.80","article-title":"The multifactorial role of neutrophils in rheumatoid arthritis","volume":"10","author":"Wright","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"2021120808115213100_cei12970-bib-0009","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.smim.2016.03.004","article-title":"Human neutrophils in auto-immunity","volume":"28","author":"Thieblemont","year":"2016","journal-title":"Semin Immunol"},{"key":"2021120808115213100_cei12970-bib-0010","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1093\/rheumatology\/keq045","article-title":"Neutrophil function in inflammation and inflammatory diseases","volume":"49","author":"Wright","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"2021120808115213100_cei12970-bib-0011","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nri3024","article-title":"Neutrophils in the activation and regulation of innate and adaptive immunity","volume":"11","author":"Mantovani","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"2021120808115213100_cei12970-bib-0012","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1084\/jem.20131241","article-title":"A molecular basis for the association of the HLA-DRB1 locus, citrullination, and rheumatoid arthritis","volume":"210","author":"Scally","year":"2013","journal-title":"J Exp Med"},{"key":"2021120808115213100_cei12970-bib-0013","doi-asserted-by":"crossref","first-page":"178ra40","DOI":"10.1126\/scitranslmed.3005580","article-title":"NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis","volume":"5","author":"Khandpur","year":"2013","journal-title":"Sci Transl Med"},{"key":"2021120808115213100_cei12970-bib-0014","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1136\/annrheumdis-2012-202765","article-title":"Antibodies from patients with rheumatoid arthritis target citrullinated histone 4 contained in neutrophils extracellular traps","volume":"73","author":"Pratesi","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2021120808115213100_cei12970-bib-0015","first-page":"3135","article-title":"Release of active peptidyl arginine deiminases by neutrophils can explain production of extracellular citrullinated autoantigens in rheumatoid arthritis synovial fluid. Arthritis","volume":"67","author":"Spengler","year":"2015","journal-title":"Rheumatol"},{"key":"2021120808115213100_cei12970-bib-0016","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1083\/jcb.200806072","article-title":"Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation","volume":"184","author":"Wang","year":"2009","journal-title":"J Cell Biol"},{"key":"2021120808115213100_cei12970-bib-0017","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1002\/jcph.354","article-title":"The pharmacokinetics, pharmacodynamics, and safety of baricitinib, an oral JAK 1\/2 inhibitor, in healthy volunteers","volume":"54","author":"Shi","year":"2014","journal-title":"J Clin Pharmacol"},{"key":"2021120808115213100_cei12970-bib-0018","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1002\/art.38779","article-title":"Analysis of infections and all-cause mortality in phase II, phase III, and long-term extension studies of tofacitinib in patients with rheumatoid arthritis","volume":"66","author":"Cohen","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2021120808115213100_cei12970-bib-0019","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1189\/jlb.5A0116-022R","article-title":"Low-density granulocytes: functionally distinct, immature neutrophils in rheumatoid arthritis with altered properties and defective TNF signalling","volume":"101","author":"Wright","year":"2017","journal-title":"J Leukoc Biol"},{"key":"2021120808115213100_cei12970-bib-0020","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1124\/dmd.113.054940","article-title":"The pharmacokinetics, metabolism, and clearance mechanisms of tofacitinib, a janus kinase inhibitor, in humans","volume":"42","author":"Dowty","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"2021120808115213100_cei12970-bib-0021","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1093\/rheumatology\/keu035","article-title":"Effects of IL-6 and IL-6 blockade on neutrophil function in vitro and in vivo","volume":"53","author":"Wright","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"2021120808115213100_cei12970-bib-0022","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1136\/ard.2010.138065","article-title":"Changes in expression of membrane TNF, NF-{kappa}B activation and neutrophil apoptosis during active and resolved inflammation","volume":"70","author":"Wright","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2021120808115213100_cei12970-bib-0023","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/rheumatology\/keu299","article-title":"Interferon gene expression signature in rheumatoid arthritis neutrophils correlates with a good response to TNFi therapy","volume":"54","author":"Wright","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"2021120808115213100_cei12970-bib-0024","doi-asserted-by":"crossref","first-page":"e58598","DOI":"10.1371\/journal.pone.0058598","article-title":"RNA-seq reveals activation of both common and cytokine-specific pathways following neutrophil priming","volume":"8","author":"Wright","year":"2013","journal-title":"PLOS ONE"},{"key":"2021120808115213100_cei12970-bib-0025","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/rheumatology\/ker338","article-title":"Analysis of SF and plasma cytokines provides insights into the mechanisms of inflammatory arthritis and may predict response to therapy","volume":"51","author":"Wright","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"2021120808115213100_cei12970-bib-0026","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1126\/science.1087061","article-title":"Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor","volume":"302","author":"Changelian","year":"2003","journal-title":"Science"},{"key":"2021120808115213100_cei12970-bib-0027","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1002\/1529-0131(200007)43:7<1488::AID-ANR11>3.0.CO;2-G","article-title":"Inhibition of neutrophil migration soon after initiation of treatment with leflunomide or methotrexate in patients with rheumatoid arthritis: findings in a prospective, randomized, double-blind clinical trial in fifteen patients","volume":"43","author":"Kraan","year":"2000","journal-title":"Arthritis Rheum"},{"key":"2021120808115213100_cei12970-bib-0028","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3892\/ijo.2014.2761","article-title":"Macrophage-secreted IL-8 induces epithelial\u2013mesenchymal transition in hepatocellular carcinoma cells by activating the JAK2\/STAT3\/Snail pathway","volume":"46","author":"Fu","year":"2015","journal-title":"Int J Oncol"},{"key":"2021120808115213100_cei12970-bib-0029","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1023\/A:1021460517468","article-title":"NADPH oxidase priming and p47phox phosphorylation in neutrophils from synovial fluid of patients with rheumatoid arthritis and spondylarthropathy","volume":"26","author":"El Benna","year":"2002","journal-title":"Inflammation"},{"key":"2021120808115213100_cei12970-bib-0030","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1182\/blood.V88.11.4330.bloodjournal88114330","article-title":"Demonstration of reversible priming of human neutrophils using platelet-activating factor","volume":"88","author":"Kitchen","year":"1996","journal-title":"Blood"},{"key":"2021120808115213100_cei12970-bib-0031","first-page":"885","article-title":"Delayed neutrophil apoptosis in very early rheumatoid arthritis patients is abrogated by methotrexate therapy","volume":"25","author":"Weinmann","year":"2007","journal-title":"Clin Exp Rheumatol"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcei.12970","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/189\/2\/250\/41644080\/cei12970.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/189\/2\/250\/41644080\/cei12970.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T16:27:53Z","timestamp":1641054473000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/189\/2\/250\/6411948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,20]]},"references-count":31,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,4,20]]},"published-print":{"date-parts":[[2017,7,13]]}},"URL":"https:\/\/doi.org\/10.1111\/cei.12970","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,8]]},"published":{"date-parts":[[2017,4,20]]}}}